Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sustainable Conversion Ventures (SCV) is a venture capital firm specializing in the industrial biotechnology and sustainable chemistry sectors. The firm focuses on early-stage investments in companies developing technologies to convert biomass and other renewable feedstocks into fuels, chemicals, and materials. SCV's investment strategy emphasizes scalable platforms that offer significant environmental benefits and cost advantages over traditional petroleum-based methods. Beyond providing capital, the firm leverages its industry expertise to support portfolio companies through technical development and commercialization phases. Notable areas of interest include synthetic biology, bio-catalysis, and advanced fermentation processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sustainable Conversion Ventures.